Table 1:

The comparison of outcomes between VATS and RATS

CharacteristicsLateral approach
Subxiphoid approach
VATS (n = 122)RATS (n = 62)P-valueVATS (n = 98)RATS (n = 52)P-value
Conversion to open surgery (%)1 (0.82)0 (0.00)>0.990.000.00/
Drainage volume (ml)260 (130–400)208 (65–390)0.24180 (60–310)283 (110–600)<0.001
Catheter retention time (day)3.0 (2.0–3.0)2.0 (1.0–3.0)<0.0012.0 (2.0–3.0)3.0 (2.0–3.0)0.03
Postoperative stay (day)3.0 (3.0–5.0)3.0 (2.0–4.0)0.0023.0 (3.0–5.0)4.0 (3.0–5.0)0.17
Second operation (%)0.000.00/0.000.00/
Complications occurred within 30 days after surgery (%)21 (17.21)2 (3.23)<0.00113 (13.27)8 (15.38)0.68
Clavien Dindo≥III15 (12.30)1 (1.61)<0.00110 (10.20)5 (9.62)>0.99
 Myasthenia gravis0.000.00/1 (1.02)0 (0.00)>0.99
 Hoarseness0.000.00/0.000.00/
 Pulmonary infection6 (4.92)1 (1.61)0.162 (2.04)4 (7.69)0.06
 Pulmonary atelectasis0.000.00/0.000.00/
 Pleural effusion9 (7.38)1 (1.61)0.035 (5.10)4 (7.69)0.56
 Arrhythmia0.000.00/0.000.00/
 DVT0.000.00/0.000.00/
 Incision infection0.000.00/0.000.00/
 Chylothorax0.000.00/0.000.00/
 Postoperative haemorrhage7 (5.74)0 (0.00)0.025 (5.10)1 (1.92)0.26
Readmission within 30 days0.000.00/1 (1.02)0.00>0.99
CharacteristicsLateral approach
Subxiphoid approach
VATS (n = 122)RATS (n = 62)P-valueVATS (n = 98)RATS (n = 52)P-value
Conversion to open surgery (%)1 (0.82)0 (0.00)>0.990.000.00/
Drainage volume (ml)260 (130–400)208 (65–390)0.24180 (60–310)283 (110–600)<0.001
Catheter retention time (day)3.0 (2.0–3.0)2.0 (1.0–3.0)<0.0012.0 (2.0–3.0)3.0 (2.0–3.0)0.03
Postoperative stay (day)3.0 (3.0–5.0)3.0 (2.0–4.0)0.0023.0 (3.0–5.0)4.0 (3.0–5.0)0.17
Second operation (%)0.000.00/0.000.00/
Complications occurred within 30 days after surgery (%)21 (17.21)2 (3.23)<0.00113 (13.27)8 (15.38)0.68
Clavien Dindo≥III15 (12.30)1 (1.61)<0.00110 (10.20)5 (9.62)>0.99
 Myasthenia gravis0.000.00/1 (1.02)0 (0.00)>0.99
 Hoarseness0.000.00/0.000.00/
 Pulmonary infection6 (4.92)1 (1.61)0.162 (2.04)4 (7.69)0.06
 Pulmonary atelectasis0.000.00/0.000.00/
 Pleural effusion9 (7.38)1 (1.61)0.035 (5.10)4 (7.69)0.56
 Arrhythmia0.000.00/0.000.00/
 DVT0.000.00/0.000.00/
 Incision infection0.000.00/0.000.00/
 Chylothorax0.000.00/0.000.00/
 Postoperative haemorrhage7 (5.74)0 (0.00)0.025 (5.10)1 (1.92)0.26
Readmission within 30 days0.000.00/1 (1.02)0.00>0.99
Table 1:

The comparison of outcomes between VATS and RATS

CharacteristicsLateral approach
Subxiphoid approach
VATS (n = 122)RATS (n = 62)P-valueVATS (n = 98)RATS (n = 52)P-value
Conversion to open surgery (%)1 (0.82)0 (0.00)>0.990.000.00/
Drainage volume (ml)260 (130–400)208 (65–390)0.24180 (60–310)283 (110–600)<0.001
Catheter retention time (day)3.0 (2.0–3.0)2.0 (1.0–3.0)<0.0012.0 (2.0–3.0)3.0 (2.0–3.0)0.03
Postoperative stay (day)3.0 (3.0–5.0)3.0 (2.0–4.0)0.0023.0 (3.0–5.0)4.0 (3.0–5.0)0.17
Second operation (%)0.000.00/0.000.00/
Complications occurred within 30 days after surgery (%)21 (17.21)2 (3.23)<0.00113 (13.27)8 (15.38)0.68
Clavien Dindo≥III15 (12.30)1 (1.61)<0.00110 (10.20)5 (9.62)>0.99
 Myasthenia gravis0.000.00/1 (1.02)0 (0.00)>0.99
 Hoarseness0.000.00/0.000.00/
 Pulmonary infection6 (4.92)1 (1.61)0.162 (2.04)4 (7.69)0.06
 Pulmonary atelectasis0.000.00/0.000.00/
 Pleural effusion9 (7.38)1 (1.61)0.035 (5.10)4 (7.69)0.56
 Arrhythmia0.000.00/0.000.00/
 DVT0.000.00/0.000.00/
 Incision infection0.000.00/0.000.00/
 Chylothorax0.000.00/0.000.00/
 Postoperative haemorrhage7 (5.74)0 (0.00)0.025 (5.10)1 (1.92)0.26
Readmission within 30 days0.000.00/1 (1.02)0.00>0.99
CharacteristicsLateral approach
Subxiphoid approach
VATS (n = 122)RATS (n = 62)P-valueVATS (n = 98)RATS (n = 52)P-value
Conversion to open surgery (%)1 (0.82)0 (0.00)>0.990.000.00/
Drainage volume (ml)260 (130–400)208 (65–390)0.24180 (60–310)283 (110–600)<0.001
Catheter retention time (day)3.0 (2.0–3.0)2.0 (1.0–3.0)<0.0012.0 (2.0–3.0)3.0 (2.0–3.0)0.03
Postoperative stay (day)3.0 (3.0–5.0)3.0 (2.0–4.0)0.0023.0 (3.0–5.0)4.0 (3.0–5.0)0.17
Second operation (%)0.000.00/0.000.00/
Complications occurred within 30 days after surgery (%)21 (17.21)2 (3.23)<0.00113 (13.27)8 (15.38)0.68
Clavien Dindo≥III15 (12.30)1 (1.61)<0.00110 (10.20)5 (9.62)>0.99
 Myasthenia gravis0.000.00/1 (1.02)0 (0.00)>0.99
 Hoarseness0.000.00/0.000.00/
 Pulmonary infection6 (4.92)1 (1.61)0.162 (2.04)4 (7.69)0.06
 Pulmonary atelectasis0.000.00/0.000.00/
 Pleural effusion9 (7.38)1 (1.61)0.035 (5.10)4 (7.69)0.56
 Arrhythmia0.000.00/0.000.00/
 DVT0.000.00/0.000.00/
 Incision infection0.000.00/0.000.00/
 Chylothorax0.000.00/0.000.00/
 Postoperative haemorrhage7 (5.74)0 (0.00)0.025 (5.10)1 (1.92)0.26
Readmission within 30 days0.000.00/1 (1.02)0.00>0.99
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close